سعر انتر اليبيد 10% محلول تنقيط وريدي 2026

Intralipid 10%: soybean-oil lipid emulsion with egg phospholipids for intravenous infusion (Fresenius Kabi), used as an energy and essential fatty acid source in parenteral nutrition. Container volume not stated by the Egyptian sources.

• Known hypersensitivity to egg, soybean, peanut or any ingredient.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Severe disorders of lipid metabolism with hypertriglyceridaemia (serum triglycerides > 1,000 mg/dL).General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Acute respiratory distress, metabolic acidosis and death have been reported after rapid infusion of intravenous lipid emulsions in neonates and infants.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Risk of parenteral nutrition-associated liver disease with prolonged PN, especially in preterm neonates; monitor liver tests.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Hypersensitivity reactions, infections, fat overload syndrome, refeeding syndrome and hypertriglyceridaemia may occur; monitor and stop infusion if reactions occur.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Recommended doses are not expected to cause major birth defects, miscarriage or other adverse maternal or fetal outcomes (US label for the 20% product).General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Recommended doses are not expected to harm a breastfed infant (US label for the 20% product).General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Serum triglycerides (baseline and during therapy), fluid and electrolytes, liver function tests.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

English text not available for this section.